20200827 News Clippings
20200827 CTV News, “Opportunity ‘over’ to test potential COVID-19 vaccine in Canada after China halts shipment” (Shame on China)
” CanSino’s vaccine was developed using a cell line from the NRC that was previously used to produce an Ebola vaccine. The two organizations have worked together since 2013.
Clinical pharmacologist Sabina Vohra-Miller says handing over that kind of asset without securing intellectual property rights on the vaccine was a major missed opportunity for Canada.
“This is a miss because you wouldn’t have that by-product if you didn’t have that foundational system of the cell line,” she told CTV News.ca.
“We’re trying to be the noblest citizens in terms of advancing science and making sure that there is no gatekeeping with that, and you would expect that there would be a reciprocity on that.”“